FOXP1 establishes interactions with the PBAF subtype to which PBRM1 belongs, binds to the PD-L1 enhancer, and promotes PD-L1 transcription, resulting in tumor immune escape (Fig. 10b). Here, PBRM1 is linked to neoplasm.